# EDGAR Filing Document

**Accession Number:** 0000895665
**File Stem:** 0001493152-23-001298
**Filing Date:** 2023-1
**Character Count:** 15632
**Document Hash:** df41444ee5cf5a833366e55553b9c841
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-001298.hdr.sgml**: 20230112

**ACCESSION NUMBER**: 0001493152-23-001298

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230112

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230112

**DATE AS OF CHANGE**: 20230112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Clearday, Inc.
- **CENTRAL INDEX KEY:** 0000895665
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
- **IRS NUMBER:** 770158076
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21074
- **FILM NUMBER:** 23526034

**BUSINESS ADDRESS:**
- **STREET 1:** 15511 W. STATE HWY 71
- **STREET 2:** SUITE 110-105
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
- **BUSINESS PHONE:** 512-650-7775

**MAIL ADDRESS:**
- **STREET 1:** 15511 W. STATE HWY 71
- **STREET 2:** SUITE 110-105
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SUPERCONDUCTOR TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19940214

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event Reported): January 12, 2023 (January 11, 2023)

**Clearday, Inc.**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-21074** | **77-0158076** |
| (State or Other Jurisdiction<br> of Incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification Number) |

---

**8800 Village Drive, Suite 106, San Antonio, TX 78217**

(Address of Principal Executive Offices) (Zip Code)

**(210) 451-0839**

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 | CLRD | OTCQX |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**ITEM 7.01 REGULATION FD DISCLOSURE.**

Clearday, Inc. (the "<u>Company</u>") issued a press release that is attached as an exhibit to this Current Report on Form 8-K announcing the expansion of the TRECS Institute grant application program that is expected to be used to access funds for skilled nursing facilities to purchase Mitra robots from Clearday that will have Clearday's full suite of robotic services including its proprietary digital programming, "Clearday at Home".

In accordance with General Instruction B.2 of Form 8-K, the information set forth herein and in Exhibit 99.1 hereto is deemed to be "furnished" and shall not be deemed to be "filed" for purposes of the Exchange Act. The information set forth in Item 7.01 of this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the management of the Company, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "anticipate," "plan," "likely," "believe," "estimate," "project," "intend," and other similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the risks regarding the Company and its business, generally; risks related to the Company's ability to correctly estimate and manage its operating expenses and develop its innovate non-acute care businesses and the acceptance of its proposed products and services, including with respect to future financial and operating results; the ability of the Company to protect its intellectual property rights; competitive responses to the Company's businesses including its innovative non-acute care business; unexpected costs, charges or expenses; regulatory requirements or developments; changes in capital resource requirements; and legislative, regulatory, political and economic developments. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Company's most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC and the registration statement regarding the Company's previously announced merger, that was filed and declared effective. The Company can give no assurance that the actual results will not be materially different than those based on the forward looking statements. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **No.** | **Description** |
| 99.1 | [Form of the Press Release issued on January 11, 2023 (furnished herewith)](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CLEARDAY, INC.** | **CLEARDAY, INC.** |
|  | By: | ***/s/ James Walesa*** |
|  | Name: | James Walesa |
|  | Title: | Chief Executive Officer |
| Dated January 12, 2023 |  |  |

---

## Exhibit 99.1

**Exhibit 99.1**

![Logo Description automatically generated with medium confidence](ex99-1_001.jpg)

**Clearday's Companion Robotics Robot Mitra Shows Tremendous Acceptance by TRECS Institute which Expanded their Grant Application Program Into 30 States for the 1<sup>st</sup> qtr. of 2023**

**San Antonio, Texas January 11, 2023 (GlobeNewswire) - Clearday, Inc. (OTCQX: CLRD)** is pleased to see wide range acceptance of the Company's Mitra Robot by TRECS Institute, which announced that they will expand their Grant Application Program to apply for state Civil Money Penalty Funds to purchase of Mitra Robots into 30 states during the 1<sup>st</sup> quarter of 2023 and further expand its program to the remaining states by the end of the 2<sup>nd</sup> quarter of 2023. Each grant is expected to request approximately $500,000 to fund 12-16 Mitra Robots for approximately 3-4 skilled nursing homes in each state and is expected to take 90 to 120 days to process. Clearday believes that TRECS' has significant experience in making applications for state Civil Money Penalty Funds with approximately 70% of the number of their grant requests approved, although there can be no assurance that this success rate will continue or be indicative of success of the Grant Application Program.

Clearday and TRECS are working together to introduce companion robots into leading skilled nursing homes to support cost savings, limit hospital readmissions and relieve caregiver burnout. Clearday and TRECS intend that the funds from the Civil Money Penalty Funds will finance the purchase of Clearday robots and related service that will foster innovation in the industry. Clearday and TRECS intend to identify skilled care communities and nursing homes in each state that are early adopters of technology to greatly improve elder care. The US Census Bureau estimates that adults over 65 will grow from 72 million today to 82 million in 2030. Today 53 million Americans are unpaid caregivers, according to AARP.

John Whitman, Founder of TRECS, formed TRECS because he "recognized the need for creative thinking in this market. TRECS is designed to be a catalyst to bring needed change to the Care industry that will improve the overall quality of Care in the most cost-effective manner possible."

TRECS has previously identified and selected skilled care communities in Pennsylvania and has expanded its Grant Application Program to identify and select skilled care communities in Florida, and North Carolina for the Clearday Mitra robot. These additional communities would provide a significant footprint in North Carolina and Florida to accelerate robotics in those states. Mr. Whitman said, "It is important to have leadership support and strong community buy-in to truly be an early adopter of technology like Companion Robotics." Caring.com reports there are 427 skilled nursing communities in North Carolina and 698 in Florida.

James Walesa, Founder and CEO of Clearday, said, "I could not be more thrilled with the TRECS Institute's commitment to our work together to revolutionize elder care. The number of facilities in North Carolina and Florida provide a large market for Clearday to offer the Mitra companion robot and services. Clearday and TRECS planned to apply to all 50 states to get Civil Penalty Funds to support robotic care and very quickly has 3 states in our grant application pipeline giving us confidence that we are on target to meet our goal of making grant application in all 50 states to finance robotics in 2023."

Mr. Walesa went on to say, "The ability to work with over 100 skilled/nursing communities in the coming year is awesome. The opportunity to provide our robotics to over 15,000 patients and residents will be exceptionally rewarding both emotionally and financially to Clearday."

*<u>About Clearday<sup>™</sup></u>*

Clearday<sup>™</sup> is an innovative non-acute longevity healthcare services company with a modern, hopeful vision for making high-quality care options more accessible, affordable, and empowering for older Americans and those who love and care for them. Clearday has a decade-long experience in non-acute care through its subsidiary Memory Care America, which operates highly rated residential memory care communities in four U.S. states. Clearday at Home – its digital service – brings Clearday to the intersection of telehealth, Software-as-a-Service (SaaS), and subscription-based content. Learn more about Clearday at <u>www.myclearday.com</u>.

*<u>About The</u> <u>TRECS Institute – Targeting Revolutionary Elder Care Solutions</u>*

The mission of "The TRECS Institute" is to identify, research, test and promote opportunities that improve the quality of care provided to senior citizens and others in need of long-term care support, in the most cost-effective manner possible, regardless of care setting. In recognizing that the quality of care provided to the elderly is so closely tied to the commitment and training of the individual worker, TRECS will place recruitment, training and retention of staff at all organizational levels a top priority. Having recognized the positive impact technology can have, not only in improving the quality of care but also in controlling costs, another focus of the TRECS Institute will be to find technology that can be integrated into the industry to achieve our goals. Finally, once improvements have been identified, The TRECS Institute is committed to making those findings available to facilities across the Nation, maximizing the impact of these positive and successful initiatives in better caring for our nation's senior citizens. Learn more about TRECS at <u>http://thetrecsinstitute.org</u>.

*<u>Forward-Looking Statements</u>*

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of terms such as "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "potential," "predict," "should," "will," "expect," "objective," "projection," "forecast," "goal," "guidance," "outlook," "effort," "target," "trajectory," "focus," "work to," "attempt," "pursue," or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances and are not guarantees of future performance. Actual results may differ materially from those indicated by forward-looking statements as a result of various factors, risks and uncertainties. These forward-looking statements should not be relied upon as representing Clearday's views as of any date subsequent to the date hereof. This release includes information from third sources from published reports providing such information and we have assumed the accuracy of such reports without independent investigation or inquiry. This communication is for informational purposes only and is neither an offer to sell nor a solicitation of an offer to purchase any securities of the Company.

Media Inquiries

Investor Relations

Ginny Connolly

<u>info@myclearday.com</u>

210-451-0839